These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21834951)

  • 21. Dysplastic nevi.
    Farber MJ; Heilman ER; Friedman RJ
    Dermatol Clin; 2012 Jul; 30(3):389-404. PubMed ID: 22800547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dysplastic melanocytic nevus].
    Salava A; Ranki A; Saksela O
    Duodecim; 2010; 126(21):2492-501. PubMed ID: 21171474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular testing of borderline cutaneous melanocytic lesions: SNP array is more sensitive and specific than FISH.
    Carter MD; Durham AB; Miedema JR; Harms PW; Chan MP; Patel RM; Lowe L; Fullen DR; Hristov AC; Wang M; Andea AA
    Hum Pathol; 2019 Apr; 86():115-123. PubMed ID: 30576704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular testing for melanocytic tumors: a practical update.
    Andea AA
    Histopathology; 2022 Jan; 80(1):150-165. PubMed ID: 34958511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements.
    Chandler WM; Rowe LR; Florell SR; Jahromi MS; Schiffman JD; South ST
    Arch Pathol Lab Med; 2012 Aug; 136(8):947-55. PubMed ID: 22849744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The differential expression of micro-RNAs 21, 200c, 204, 205, and 211 in benign, dysplastic and malignant melanocytic lesions and critical evaluation of their role as diagnostic biomarkers.
    Quiohilag K; Caie P; Oniscu A; Brenn T; Harrison D
    Virchows Arch; 2020 Jul; 477(1):121-130. PubMed ID: 32388720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The dysplastic nevus. Separate entity, melanoma precursor or diagnostic dilemma?
    Roesch A; Landthaler M; Vogt T
    Hautarzt; 2003 Sep; 54(9):871-83; quiz 884-5. PubMed ID: 14575036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinguishing epithelioid blue nevus from blue nevus-like cutaneous melanoma metastasis using fluorescence in situ hybridization.
    Pouryazdanparast P; Newman M; Mafee M; Haghighat Z; Guitart J; Gerami P
    Am J Surg Pathol; 2009 Sep; 33(9):1396-400. PubMed ID: 19606012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Fluorescence in-situ hybridization as a diagnostic tool for cutaneous melanoma].
    Su J; Liu J; Zheng J; You J; Ma X; Zhang Y; Zhang J; Liao S
    Zhonghua Bing Li Xue Za Zhi; 2015 Jan; 44(1):37-41. PubMed ID: 25765029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
    Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R
    Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of dermoscopy on the management of high-risk patients from melanoma families: a prospective study.
    van der Rhee JI; Bergman W; Kukutsch NA
    Acta Derm Venereol; 2011 Jun; 91(4):428-31. PubMed ID: 21625824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A fluorescence in situ hybridization (FISH) procedure to assist in differentiating benign from malignant melanocytic lesions.
    Clemente C; Bettio D; Venci A; Scopsi L; Rao S; Ferrari A; Piris A; Mihm MC
    Pathologica; 2009 Oct; 101(5):169-74. PubMed ID: 20218056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Guidelines for histopathologic diagnosis of plantar malignant melanoma. Two-dimensional coordination of maximum diameters of lesions and degrees of intraepidermal proliferation of melanocytes.
    Saida T; Yoshida N
    Dermatologica; 1990; 181(2):112-6. PubMed ID: 2242777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on fluorescence in situ hybridization in melanoma: state of the art.
    Gerami P; Zembowicz A
    Arch Pathol Lab Med; 2011 Jul; 135(7):830-7. PubMed ID: 21732770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi.
    Gerami P; Wass A; Mafee M; Fang Y; Pulitzer MP; Busam KJ
    Am J Surg Pathol; 2009 Dec; 33(12):1783-8. PubMed ID: 19809275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclin D1 and D3 expression in melanocytic skin lesions.
    Alekseenko A; Wojas-Pelc A; Lis GJ; Furgał-Borzych A; Surówka G; Litwin JA
    Arch Dermatol Res; 2010 Sep; 302(7):545-50. PubMed ID: 20496072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update and clinical use of imaging technologies for pigmented lesions of the skin.
    O'Donnell AT; Kim CC
    Semin Cutan Med Surg; 2012 Mar; 31(1):38-44. PubMed ID: 22361288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysplastic nevus syndrome.
    Welkovich B; Schmoeckel C; Landthaler M; Braun-Falco O
    Arch Dermatol; 1987 Oct; 123(10):1280. PubMed ID: 3662558
    [No Abstract]   [Full Text] [Related]  

  • 39. Quality assessment by expert opinion in melanoma pathology: experience of the pathology panel of the Dutch Melanoma Working Party.
    Veenhuizen KC; De Wit PE; Mooi WJ; Scheffer E; Verbeek AL; Ruiter DJ
    J Pathol; 1997 Jul; 182(3):266-72. PubMed ID: 9349228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of genetic instability in melanocytic skin lesions through microsatellite analysis of benign naevi, dysplastic naevi, and primary melanomas and their metastases.
    Palmieri G; Ascierto PA; Cossu A; Colombino M; Casula M; Botti G; Lissia A; Tanda F; Castello G
    Melanoma Res; 2003 Apr; 13(2):167-70. PubMed ID: 12690300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.